Published in Immunology on February 01, 2005
Autoamplification of Notch signaling in macrophages by TLR-induced and RBP-J-dependent induction of Jagged1. J Immunol (2010) 1.25
Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients. Clin Exp Immunol (2005) 1.14
Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3. Virology (2009) 1.09
Qualitatively distinct patterns of cytokines are released by human dendritic cells in response to different pathogens. Immunology (2005) 1.04
Lipopolysaccharide induces CXCL2/macrophage inflammatory protein-2 gene expression in enterocytes via NF-kappaB activation: independence from endogenous TNF-alpha and platelet-activating factor. Immunology (2006) 1.00
Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier. J Neuroinflammation (2012) 0.91
A comparison between isolated blood dendritic cells and monocyte-derived dendritic cells in pigs. Immunology (2009) 0.90
The modulatory effects of lipopolysaccharide-stimulated B cells on differential T-cell polarization. Immunology (2008) 0.89
The effect of cell subset isolation method on gene expression in leukocytes. Cytometry A (2013) 0.88
Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes. Transfusion (2009) 0.86
Complement opsonization of HIV-1 results in decreased antiviral and inflammatory responses in immature dendritic cells via CR3. J Immunol (2014) 0.84
High-throughput measurement of single-cell growth rates using serial microfluidic mass sensor arrays. Nat Biotechnol (2016) 0.84
Dendritic cell-based immunity and vaccination against hepatitis C virus infection. Immunology (2012) 0.83
Requirements for growth and IL-10 expression of highly purified human T regulatory cells. J Clin Immunol (2012) 0.81
Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation. BMC Cancer (2015) 0.81
Bacillus anthracis' lethal toxin induces broad transcriptional responses in human peripheral monocytes. BMC Immunol (2012) 0.80
Brain Tumor Immunotherapy: What have We Learned so Far? Front Oncol (2015) 0.79
Fetal bovine serum xenoproteins modulate human monocyte adhesion and protein release on biomaterials in vitro. Acta Biomater (2010) 0.79
CMV-specific T cell isolation from G-CSF mobilized peripheral blood: depletion of myeloid progenitors eliminates non-specific binding of MHC-multimers. J Transl Med (2014) 0.79
The Role of ATP-Binding Cassette Transporters in Neuro-Inflammation: Relevance for Bioactive Lipids. Front Pharmacol (2012) 0.78
In vitro T-cell profile induced by BCG Moreau in healthy Brazilian volunteers. Hum Vaccin Immunother (2015) 0.78
CAR-T Cell Therapies From the Transfusion Medicine Perspective. Transfus Med Rev (2016) 0.78
HIV-1 Resistant CDK2-Knockdown Macrophage-Like Cells Generated from 293T Cell-Derived Human Induced Pluripotent Stem Cells. Biology (Basel) (2012) 0.77
Human Liver Stem Cells Suppress T-Cell Proliferation, NK Activity, and Dendritic Cell Differentiation. Stem Cells Int (2016) 0.76
HCMV Displays a Unique Transcriptome of Immunomodulatory Genes in Primary Monocyte-Derived Cell Types. PLoS One (2016) 0.76
Rapid and label-free microfluidic neutrophil purification and phenotyping in diabetes mellitus. Sci Rep (2016) 0.75
The effect of ex vivo CDDO-Me activation on nuclear factor erythroid 2-related factor 2 pathway in white blood cells from patients with septic shock. Shock (2014) 0.75
Controlled-rate freezer cryopreservation of highly concentrated peripheral blood mononuclear cells results in higher cell yields and superior autologous T-cell stimulation for dendritic cell-based immunotherapy. Cancer Immunol Immunother (2012) 0.75
Human parainfluenza virus type 2 vector induces dendritic cell maturation without viral RNA replication/transcription. Hum Gene Ther (2013) 0.75
Comparison between magnetic activated cell sorted monocytes and monocyte adherence techniques for in vitro generation of immature dendritic cells: an Egyptian trial. Cent Eur J Immunol (2015) 0.75
Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl (1968) 60.35
Dendritic cells and the control of immunity. Nature (1998) 56.54
The dendritic cell system and its role in immunogenicity. Annu Rev Immunol (1991) 23.09
CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science (1990) 17.86
Tolerogenic dendritic cells. Annu Rev Immunol (2001) 13.77
Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med (1989) 10.60
Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med (1996) 9.31
BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol (2000) 6.04
Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature (1987) 4.66
CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci U S A (1996) 4.64
Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci U S A (1990) 4.60
Dendritic cells are the principal stimulators of the primary mixed leukocyte reaction in mice. J Exp Med (1983) 4.57
Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci U S A (1991) 4.48
Advanced multiplexed analysis with the FlowMetrix system. Clin Chem (1997) 4.03
The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol (2000) 3.71
The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci U S A (1990) 3.71
Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med (1999) 3.64
Dendritic cells are critical accessory cells for thymus-dependent antibody responses in mouse and in man. Proc Natl Acad Sci U S A (1983) 3.25
Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol (2001) 2.89
Effect of interleukin-10 on dendritic cell maturation and function. Eur J Immunol (1997) 2.81
Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Methods (1999) 2.73
Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J Immunol (1993) 2.20
A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol (1992) 2.09
The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr Opin Immunol (2001) 1.97
Dendritic cells as the terminal stage of monocyte differentiation. J Immunol (1998) 1.87
Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunol Today (1996) 1.74
Interleukin 4 down-regulates the expression of CD14 in normal human monocytes. Eur J Immunol (1990) 1.74
Characterization of a factor(s) which synergizes with recombinant interleukin 2 in promoting allogeneic human cytolytic T-lymphocyte responses in vitro. Cell Immunol (1988) 1.56
The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J Exp Med (2001) 1.28
Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur J Immunol (1997) 1.24
Cutting edge: CD83 regulates the development of cellular immunity. J Immunol (2002) 1.21
Interleukin-12: basic principles and clinical applications. Curr Top Microbiol Immunol (1999) 1.11
Subtractive cDNA cloning of a novel member of the Ig gene superfamily expressed at high levels in activated B lymphocytes. Blood (1993) 1.06
Interleukin-12 an integral cytokine in the immune response. Life Sci (1996) 1.04
Bacteria and bacterial cell wall constituents induce the production of regulatory cytokines in dendritic cell clones. J Inflamm (1996) 0.97
Generating potent Th1/Tc1 T cell adoptive immunotherapy doses using human IL-12: Harnessing the immunomodulatory potential of IL-12 without the in vivo-associated toxicity. J Immunother (2003) 0.93
In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapy. Exp Hematol (1997) 0.90
Th1 and Th2 cells. Res Immunol (1999) 0.83
An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer (2008) 1.95
Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists. J Urol (2007) 1.73
Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses. Cancer Treat Rev (2010) 1.43
Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4. Mol Cancer Res (2008) 1.07
Com-1/p8 acts as a putative tumour suppressor in prostate cancer. Int J Mol Med (2006) 0.94
Robotic or open radical cystectomy, which is safer? A systematic review and meta-analysis of comparative studies. J Endourol (2014) 0.93
Does the PGC-1/PPARgamma pathway play a role in Com-1/p8 mediated cell growth inhibition in prostate cancer? Int J Mol Med (2006) 0.92
Putative prognostic epithelial-to-mesenchymal transition biomarkers for aggressive prostate cancer. Exp Mol Pathol (2013) 0.87
Correlation between CD8+ T cells specific for prostate-specific antigen and level of disease in patients with prostate cancer. Clin Immunol (2006) 0.86
HGF/SF up-regulates the expression of bone morphogenetic protein 7 in prostate cancer cells. Urol Oncol (2007) 0.84
Bone morphogenetic protein-10 suppresses the growth and aggressiveness of prostate cancer cells through a Smad independent pathway. J Urol (2009) 0.82
Safety and feasibility of laparoscopic radical cystectomy for the treatment of bladder cancer. J Endourol (2013) 0.81
Differential CTLs specific for prostate-specific antigen in healthy donors and patients with prostate cancer. Int Immunol (2005) 0.81
Growth and differentiation factor 9 (GDF-9) induces epithelial-mesenchymal transition in prostate cancer cells. Mol Cell Biochem (2010) 0.80
Hepatocyte growth factor up-regulates the expression of the bone morphogenetic protein (BMP) receptors, BMPR-IB and BMPR-II, in human prostate cancer cells. Int J Oncol (2007) 0.79
A role for STEAP2 in prostate cancer progression. Clin Exp Metastasis (2014) 0.75
Comparison of the Performance of Skin Prick, ImmunoCAP, and ISAC Tests in the Diagnosis of Patients with Allergy. Int Arch Allergy Immunol (2017) 0.75
Management of lower urinary tract symptoms in men. Br J Hosp Med (Lond) (2013) 0.75